Australia moves closer to full disclosure of drug company payments to doctors: Is the UK lagging behind the US and Australia in increasing transparency?

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalComment/debate/opinionResearchpeer-review

Original languageEnglish
Article numberf3960
JournalBritish Medical Journal
Volume346
Issue number7913
DOIs
Publication statusPublished - 22 Jun 2013

Cite this